Diabetic nephropathy in insulin-dependent patients (Q35589614)

9 August 2017

1 reference

title

Diabetic nephropathy in insulin-dependent patients (English)

1 reference

9 August 2017

1 reference

J. A. Breyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462980

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1462980

29 September 2022

publication date

1 December 1992

1 reference

American Journal of Kidney Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

20

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

533-547

1 reference

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Improved survival in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Long-term outcome in diabetic patients on hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The changing natural history of nephropathy in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Natural course and prognosis of juvenile diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Is diabetic nephropathy an inherited complication?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Early functional and morphologic vascular renal consequences of the diabetic state

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Increase in Glomerular Filtration Rate in Patients with Insulin-Dependent Diabetes and Elevated Erythrocyte Sodium–Lithium Countertransport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glomerular hemodynamics in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The kidney in diabetes: significance of the early abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Relationships among natriuresis, atrial natriuretic peptide and insulin in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Renin and angiotensinogen gene expression in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Diabetic nephropathy. A perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Mean glomerular volume and rate of development of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The renal tubulointerstitium in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Diabetic nephropathy: hemodynamic basis and implications for disease management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Possible genetic defects in regulation of glycosaminoglycans in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Aldose reductase inhibitors and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Microalbuminuria in type I diabetic patients. Prevalence and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Microalbuminuria in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Microalbuminuria as a predictor of clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Pathophysiology and management of hypertension in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

High-normal blood pressure and early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Blood pressure changes and renal function in incipient and overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Arterial blood pressure related to degree of albuminuria and low-molecular-weight proteinuria in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prevalence of raised sodium-lithium countertransport activity in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Relationship of systemic blood pressure to nephropathology in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Ambulatory blood pressure in microalbuminuric type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Pathophysiology of proteinuria in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glomerular size and charge selectivity in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Measurement of renal function in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Renal papillary necrosis in patients with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Severe hypoglycemia in type I diabetic patients with impaired kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Hyporeninemic Hypoaldosteronism in Diabetic Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Long-term follow-up of 369 diabetic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Results of peritoneal dialysis in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Pancreas transplantation as therapy for diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Abnormal diastolic function in patients with type 1 diabetes and early nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of insulin therapy on established diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Relation of diabetic control to development of microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of Control of Blood Glucose on Urinary Excretion of Albumin and β2Microglobulin in Insulin-Dependent Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Glycaemic control in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effects of sorbinil on glomerular structure and function in long-term-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Reversal of proteinuria by sorbinil, an aldose reductase inhibitor in spontaneously diabetic (BB) rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Advanced non-enzymatic tissue glycosylation: significance in late diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Chronic effects of dietary protein in the rat with intact and reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect on renal function of change from high to moderate protein intake in type I diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Prolonged dietary protein restriction in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Restriction of dietary protein and progression of renal failure in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

High linoleic acid diets ameliorate diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970215-9

7 January 2021

10.1016/S0272-6386(12)70215-9

Identifiers

DOI

1 reference

9 August 2017

1 reference